Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Development of 2-[18F]trifluoromethyl-L-tryptophan (2-[18F]CF3-L-Trp) for serotonergic system imaging

Ho Young Kim
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1034;
Ho Young Kim
1nuclear medicine Seoul National University Hospital Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1034

Objectives Serotonergic system is related with various brain dysfunctions such as depression, anxiety or epilepsy. Thus, non-invasive imaging of serotonin synthesis is very important for the study of those brain diseases. However, only a few C-11 labeled radiopharmaceuticals are available, which have limitations for clinical applications. In the present study, we synthesized 2-[18F]CF3-L-Trp using copper-catalyzed [18F]trifluoromethylation and evaluated its brain distribution by autoradiography.

Methods Precursor was prepared by 7 step synthesis including regio-selective iodination. [18F]Trifluromethyl group was introduced by copper-catalyzed coupling using methyl chlorodifluoroacetate and tetramethylenediamine at 150℃ for 15 min. Protection groups were removed by 1 N HCl at 100℃ for 10 min and purified by high-performance liquid chromatography (HPLC). Radiochemical and chiral purities were also confirmed by HPLC. Stability studies were performed in prepared medium at room temperature and in human and mouse sera at 37℃. Protein binding assay was performed in human or mouse serum at 37℃ for 10 and 60 min. For the autoradiography, 2-[18F]CF3-L-Trp was injected into normal or LiCl-treated rats. The rats were killed after 10 min and the brains were removed and kept in the container with dry ice. The brains were cut into 30 μm sections using a cryostat and radioactivity was measured by Bio-imaging Analyzer System (BAS-2500).

Results Total radiosynthesis time was about 70 min and radiochemical yield was 20~30% based on HPLC. Retention time of 2-[18F]CF3-L-Trp was consistent with 2-CF3-L-Trp standard. Radiochemical purity was over 99% and specific activity was 550-900 MBq/μmol. 2-[18F]CF3-L-Trp was stable up to 6 h in mouse and human sera at 37℃ and protein-binding was 0.26±0.03 in human serum and 0.34±0.02 in mouse serum at 60 min. In autoradiography, 2-[18F]CF3-L-trp showed the highest uptake in pineal gland (5.41% ID/g) and showed high uptake in raphe nucleus (2.36% ID/g) , mammillary body (2.05% ID/g) and hypothalamus (2.36% ID/g). Compared to the normal rat brain, overall uptake of 2-[18F]CF3-L-Trp in LiCl-treated rat brain was higher except in pineal gland.

Conclusions [18F]CF3-L-Trp was successfully synthesized by transition metal catalyzed coupling. Its distribution pattern in the brain demonstrated serotonin neuron distribution. We expect that 2-[18F]CF3-L-Trp could be used as an imaging agent representing serotonin synthesis and metabolism non-invasively

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Development of 2-[18F]trifluoromethyl-L-tryptophan (2-[18F]CF3-L-Trp) for serotonergic system imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Development of 2-[18F]trifluoromethyl-L-tryptophan (2-[18F]CF3-L-Trp) for serotonergic system imaging
Ho Young Kim
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1034;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Development of 2-[18F]trifluoromethyl-L-tryptophan (2-[18F]CF3-L-Trp) for serotonergic system imaging
Ho Young Kim
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1034;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

SPECIAL MTA: Preclinical Probes for Neuroimaging Posters

  • [18F]FLT - A new stem cell label for in vivo tracking with positron emission tomography
  • Flourine-18 labeling of electron-rich 5-HT2A agonists
  • Synthesis and Evaluation of PET Radiotracers for the Presynaptic High-affinity Choline Transporter
Show more SPECIAL MTA: Preclinical Probes for Neuroimaging Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire